Randomized, Placebo-controlled, Double-Blind, Parallel Design, Phase 3 Study to Assess the Safety and Efficacy of Udenafil Tablets in Male Subjects With Erectile Dysfunction.
Phase of Trial: Phase III
Latest Information Update: 21 Dec 2011
At a glance
- Drugs Udenafil (Primary)
- Indications Erectile dysfunction
- Focus Registrational; Therapeutic Use
- Sponsors Warner Chilcott
- 12 Aug 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 12 Aug 2010 Actual end date (Mar 2010) added as reported by ClinicalTrials.gov.
- 23 Dec 2009 Planned number of patients (560), official title and primary end point added and lead trial investigator (Herman Ellman) identified as reported by ClinicalTrials.gov.